India Fights Back : Plasma Therapy Advisory

The country's apex health research body, ICMR, has issued an advisory stating that indiscriminate use of Convalescent Plasma Therapy (CPT) in coronavirus infected patients is not advisable.

In an "Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients", the ICMR said that a potential donor for convalescent plasma should have sufficient concentration of antibody working against COVID-19.

CPT or passive immunotherapy has been tried in the past for treatment of viral infections like H1N1, Ebola and SARS-CoV-1 etc.

In this edition of Covid-19 – India Fights Back we analyse the status of plasma therapy.

Anchor - Frank Rausan Pereira

Producer - Saumya Nanda


a) Dr. Saurabh Mittal, Asst. Professor, Pulmonary Medicine, AIIMS Delhi

b) Dr. Aparna Mukherjee, Scientist E, ICMR

c) Dr. Meenu Bajpai, Professor, Transfusion Medicine, ILBS
Be the first to comment